In this study, we have analysed the prevalence of PALB2 mutations in a cohort of 122 familial breast cancer cases who do not have alterations in BRCA1 or BRCA2 and found 2 (1.3%) were PALB2 carriers. Here, BRCA2 is linked to breast carcinoma.